ChinaDaily Briefs

Daily Brief China: Chindata Group, Shougang Fushan Resources, Playmates Toys, Ant Financial Services Group, J&T Global Express, BeiGene Ltd, Syngenta Group, Tencent, Shui On Land and more

In today’s briefing:

  • Chindata: Bain’s Move Spurs China Merchants Into Action
  • Shougang Fushan Resources (639 HK): Partial Offer at HK$2.40
  • Playmates Toys: Movie and Toy Reviews TMNT Mutant Mayhem Suggest Big Upside Ahead
  • Ant Group Proposes Share Buyback at Roughly 30% of IPO Valuation
  • J&T Global Express Pre-IPO, Part 3: ‘New Markets’ & X-Border | Our Initial EV Estimate Is US$8.6 Bn
  • BeiGene (6160.HK/​BGNE.US) – Novatis Chose to Escape Before Tragedy of TIGIT Truly Comes
  • Syngenta Pre-IPO – The Negatives – Margins Remain Razor Thin and Parent on Sanction List
  • [Tencent (700 HK, BUY, TP HK$450) TP Change]: “DNF Mobile” And Strong Ads Are Two Catalysts
  • Morning Views Asia: Agung Podomoro Land, Shui On Land


Chindata: Bain’s Move Spurs China Merchants Into Action

By David Blennerhassett

  • My read of Bain’s Offer last month, was a tactic to flesh out a competing Offer.  It seemed unlikely Bain would get the regulatory approval to take Chindata (CD US) private. 
  • Now state-backed China Merchants Capital Holdings International Ltd. has made a non-binding offer of $9.20/ADS, compared to $8/ADS from Bain.
  • This Offer is indicative. But an SOE taking over data centres makes a lot of sense. 

Shougang Fushan Resources (639 HK): Partial Offer at HK$2.40

By Arun George

  • Shougang Fushan Resources (639 HK) has launched a partial offer to acquire a maximum of 125.0m shares (2.47% of outstanding) at HK$2.40 per share, a 17.6% premium to the undisturbed price.
  • The partial offer is conditional on approval by more than 50% of disinterested shares and the shareholder approval of the whitewash waiver. There is no minimum acceptance condition.
  • The 2020 partial offer, which was at a 9.3% premium to the undisturbed price and -17% below the current offer, was overwhelmingly approved. Therefore, the current offer should be approved.  

Playmates Toys: Movie and Toy Reviews TMNT Mutant Mayhem Suggest Big Upside Ahead

By Nicolas Van Broekhoven

  • Three weeks ahead of the global launch of TMNT Mutant Mayhem momentum is building
  • Google Trends searches reveal rising interest in both movies and toys
  • Risk/Reward is still highly attractive, last time a TMNT movie was a success stock hit 4 HKD

Ant Group Proposes Share Buyback at Roughly 30% of IPO Valuation

By Caixin Global

  • Ant Group Co. Ltd. has offered to buy back some shares at a whopping 70% discount to the unrealized valuation for its ill-fated IPO, shortly after regulators hit the fintech giant with an almost $1 billion fine.
  • Ant Group announced Saturday that it had proposed to repurchase as much as 7.6% at a price that values the company at approximately 567 billion yuan ($78 billion).
  • The offer represents a roughly 40% discount to the approximate 960 billion yuan figure achieved in Ant Group’s last fundraising round in 2018, and is around 70% cheaper than the 2.1 trillion yuan valuation touted in its planned 2020 IPO.

J&T Global Express Pre-IPO, Part 3: ‘New Markets’ & X-Border | Our Initial EV Estimate Is US$8.6 Bn

By Daniel Hellberg

  • After analyzing J&T’s Chinese and SE Asian operations in previous insights, in this note we turn to the company’s ‘Others’ segment, made up of New Markets and X-Border logistics
  • Compared to China and SE Asia, J&T’s New Markets and X-Border logistics business lines are small (just 11% of 2022 Revenue) but could offer attractive growth in the medium-term
  • We conclude this insight with a preliminary sum-of-parts valuation of J&T as a whole. Based on available information, our initial estimate of J&T’s EV is US$8.6 bn (pre-IPO)

BeiGene (6160.HK/​BGNE.US) – Novatis Chose to Escape Before Tragedy of TIGIT Truly Comes

By Xinyao (Criss) Wang

  • BeiGene and Novartis mutually terminate the Option Agreement on ociperlimab. Our interpretation is Novartis may think its clinical data wouldn’t meet expectations, and is therefore unwilling to take the risk.
  • Theoretically, BeiGene still has the possibility of creating miracles to turn things around, but based on the current situation, the risk of TIGIT project failure is already very high.
  • We suggest that investors can reduce the position of BeiGene in advance or even consider offload entirely (In case its stock price falls due to unsatisfactory clinical data in 23H2).

Syngenta Pre-IPO – The Negatives – Margins Remain Razor Thin and Parent on Sanction List

By Clarence Chu

  • Syngenta Group (1844795D CH) is looking to raise around US$9.2bn in its upcoming China A-share IPO.
  • Syngenta Group (Syngenta) is one of the largest agricultural firms globally, developing, producing and commercializing a portfolio of crop protection, seeds, crop nutrition products.
  • In this note, we will talk about the not so positive aspects of the deal.

[Tencent (700 HK, BUY, TP HK$450) TP Change]: “DNF Mobile” And Strong Ads Are Two Catalysts

By Shawn Yang

  • We expect that Tencent’s 2Q23’s rev./non-IFRS net income to be 0.2%/5.2% vs cons. 
  • We raise Tencent’s ads growth in 2Q23 from 18.2% to 28.4% YoY per our recent checks with ads agencies. 
  • There is an increasing possibility that “DNF Mobile” could be launched in the next several quarters. We raise the TP to $450, which implies 20.1X PE in 2023.

Morning Views Asia: Agung Podomoro Land, Shui On Land

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars